Video Library

Summary and Transcription Coming Soon

Skin issues are a common complication after bone marrow/stem cell transplants. This presentation describes the type of skin problems that can develop, who’s at risk, and strategies to prevent or treat them.

Stem cell or bone marrow transplantation and CAR T-cell therapy can increase the risk of second cancers. This presentation describes the types and frequency of such risks along with strategies to mitigate them.

This presentation discusses current research on how the intestinal (gut) microbiome impacts patient outcomes following a bone marrow/stem cell transplant or CAR T-cell therapy.

CAR T cell therapy has become an increasingly common treatment for patients with diffuse large B-cell lymphoma, (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma. This presentation discusses how it works, who is a good candidates for CAR T-cell therapy, and the risks and benefits of the treatment.

This presentation discusses CAR T-cell therapy for multiple myeloma. It explains what CAR T-cell therapy is, the process, and what clinical trials are indicating in regards to short- and long-term side effects, patient outcomes, and quality of life.

Even when cancer treatment is initially successful, many patients experience a fear of recurrence of their illness. This presentation discusses the causes of such fears, and coping strategies that survivors can use to manage them.

Graft-versus-host-disease (GVHD) can be a significant problem after stem cell transplantation. This presentation discusses what GVHD is, risk factors for developing it and recent advances in the prevention and treatment of GVHD.

Summary and Transcription Coming Soon

Patients and their partners may have difficulty with intimacy and sexual activity after transplant or CAR T-cell therapy. This presentation explores strategies for acknowledging and addressing these issues.

Many treatment options are being studied and utilized for patients whose cancer has relapsed (come back) after a bone marrow/stem cell transplant or CAR T-cell therapy. Many clinical trials are showing increased survival outcomes, and some of these new therapies have replaced previous treatment standards.

This presentation outlines the importance of long-term follow-up care after a bone marrow/stem cell transplant using donor cells (allogeneic transplant) focused on supportive care for side effects post-transplant, identifying new health issues early, and providing resources and guidance to ensure the patient is experiencing their optimal quality of life after treatment.